“Our Xfree chemistry has proven to be highly robust in our FDA-EUA COVID-19 test. We are excited to offer expanded respiratory panels to equip our customers with cost-effective, rapid PCR workflows,” said Shahin Iqbal, Ph.D., President & COO of BioGX.
Xfree technology provides a complete lyophilized test in a single tube in the trusted BioGX Sample-Ready™ format for extraction-free, direct sample addition real-time PCR testing. This format eliminates pre-treatment and nucleic acid extraction steps, enabling labs with a simple Sample-to-Answer workflow. The test can be shipped anywhere in the world without refrigeration.
To request more information on BioGX Xfree products and our other testing solutions, please contact sales@biogx.com.
